In this page you can find the latest issue of the journal
Innovation is accelerating across the pharmaceutical landscape. In this latest issue, we examine advances in AI, cell and gene therapies, continuous manufacturing, PAT, HPAPIs and sustainable solutions, alongside exclusive interviews with industry leaders, a panel discussion on ESG and strategic partnerships in the pharma supply chain, and insights into the evolving challenges of global pharmaceutical development and manufacturing.
“Contents from Magazine” offers curated articles and insights from the field of chemistry, focused on research, data, and scientific developments
15K articles and news from our archive.
Advances in chemistry have often been tied to the development of new tools. The chemist was often the tool builder, inventing instruments to advance the field. Alchemists, natural philosophers and then chemists…
The development pipeline for precision medicines is driving sustained demand for highly potent active pharmaceutical ingredients (HPAPIs), particularly in oncology. ADC payloads and selective small-molecule therapies often require occupational exposure limits (OELs)…
Introduction On 29 September 2026, the broader phase of the Section 232 pharmaceutical tariff regime takes effect. Imported patented medicines and covered ingredients become subject to a baseline 100 percent rate, except…
How continuous flow is transforming photochemistry from laboratory promise into sustainable manufacturing reality Ajinomoto Sustainable Solutions, powered by Ajinomoto Omnichem Photochemistry is experiencing a renaissance. Across pharmaceutical, specialty chemical, agrochemical and…
Introduction The drug development industry has long accepted high attrition and extended timelines as an unavoidable cost of doing business. Although formulation science is crucial in ensuring exposure to deliver efficacy and…
Pharmaceutical Development: From Molecule to Medicine Pharmaceutical development is the complex process through which a promising molecule becomes a safe, effective, and marketable medicine. It begins with drug discovery and preclinical research,…
While specialized manufacturing assets are critically important in minimizing worker and environmental exposure to high-potency active pharmaceutical ingredients (HPAPIs), these assets are only one piece of the complex HPAPI manufacturing puzzle. The…
In an era where the global market continuously searches for a balance between nature and technology, we are witnessing the birth of entirely new standards in the health and wellness industry. Today’s…
Introduction Developing robust quality control strategies for cell and gene therapy (CGT) products is a technically demanding process for biopharmaceuticals developers. These advanced therapies have exceptional potential with equally exceptional analytical complexity:…
Bringing a new therapy from concept to clinic has never been more complex. Developers are under increasing pressure to accelerate timelines, manage technical risk, and generate robust data to support regulatory submissions,…
ISPROCHEM (International School of Process Chemistry) is an advanced training school promoted by the Organic Chemistry Division of the Italian Chemical Society (Società Chimica Italiana) and organized by the Department of Chemistry…
What Transfers, What Doesn’t Leveraging small-molecule proficiency to advance peptide and oligonucleotide manufacturing What capabilities transfer best from small molecules to TIDES? Most people would point first to technology: enzyme engineering,…
Olon has a long-standing expertise in both fermentation and chemical synthesis. How do you see these two technology platforms evolving together, and why is it important for a CDMO to continue developing…
Introduction The American Chemical Society, Green Chemistry Institute Pharmaceutical Roundtable (ACS-GCIPR) is a precompetitive collaboration of pharmaceutical and allied companies working to advance the implementation of green chemistry and engineering across the…
Introduction Continuous biomanufacturing (CBM) is an advanced manufacturing paradigm in which biological products are produced through uninterrupted, integrated processing rather than discrete batch operations (8,9). The concept has emerged as one of…
Introduction The use of PAT in pharmaceutical manufacture has a long history, with its modern regulatory guidance being formulated by the FDA in 2004 (1). In this document, the FDA encouraged a…
Pharmaceutical supply chains are amongst the most complex operational ecosystems in today’s globalized economy. At the end of the chain is the treatment for the patient. This must be safe, reliable and…
